Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -65.18 Million CNY | -394.52% |
| 2022 | 22.13 Million CNY | -65.31% |
| 2021 | 63.79 Million CNY | -81.57% |
| 2020 | 346.14 Million CNY | 434.9% |
| 2019 | 64.71 Million CNY | 0.81% |
| 2018 | 64.19 Million CNY | 11.55% |
| 2017 | 57.54 Million CNY | -14.29% |
| 2016 | 67.14 Million CNY | 180.71% |
| 2015 | 23.91 Million CNY | -29.24% |
| 2014 | 33.8 Million CNY | 16.86% |
| 2013 | 28.92 Million CNY | -20.77% |
| 2012 | 36.5 Million CNY | 8.08% |
| 2011 | 33.77 Million CNY | 2.38% |
| 2010 | 32.99 Million CNY | 61.68% |
| 2009 | 20.4 Million CNY | 93.15% |
| 2008 | 10.56 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 3.62 Million CNY | 102.8% |
| 2024 Q2 | -6.14 Million CNY | -269.34% |
| 2024 Q3 | -11.12 Million CNY | -81.14% |
| 2023 Q4 | -129.46 Million CNY | -2488.61% |
| 2023 Q1 | 27.16 Million CNY | 130.42% |
| 2023 Q2 | 31.69 Million CNY | 16.69% |
| 2023 FY | -65.18 Million CNY | -394.52% |
| 2023 Q3 | 5.42 Million CNY | -82.9% |
| 2022 FY | 22.13 Million CNY | -65.31% |
| 2022 Q3 | 3.1 Million CNY | 145.36% |
| 2022 Q1 | 13.94 Million CNY | 348.92% |
| 2022 Q2 | -6.84 Million CNY | -149.04% |
| 2022 Q4 | 11.78 Million CNY | 279.9% |
| 2021 Q2 | 28.13 Million CNY | 14.37% |
| 2021 Q1 | 24.6 Million CNY | -21.33% |
| 2021 Q3 | 16.65 Million CNY | -40.82% |
| 2021 Q4 | -5.6 Million CNY | -133.65% |
| 2021 FY | 63.79 Million CNY | -81.57% |
| 2020 FY | 346.14 Million CNY | 434.9% |
| 2020 Q4 | 31.27 Million CNY | -58.22% |
| 2020 Q3 | 74.85 Million CNY | -62.45% |
| 2020 Q2 | 199.36 Million CNY | 390.46% |
| 2020 Q1 | 40.64 Million CNY | 339.21% |
| 2019 Q4 | 9.25 Million CNY | -66.7% |
| 2019 FY | 64.71 Million CNY | 0.81% |
| 2019 Q1 | 16.13 Million CNY | 12.37% |
| 2019 Q2 | 11.53 Million CNY | -28.54% |
| 2019 Q3 | 27.79 Million CNY | 141.05% |
| 2018 Q3 | 15.78 Million CNY | 3.68% |
| 2018 Q2 | 15.22 Million CNY | -19.16% |
| 2018 Q4 | 14.35 Million CNY | -9.02% |
| 2018 FY | 64.19 Million CNY | 11.55% |
| 2018 Q1 | 18.83 Million CNY | 1162.38% |
| 2017 Q4 | 1.49 Million CNY | -91.6% |
| 2017 FY | 57.54 Million CNY | -14.29% |
| 2017 Q1 | 17.1 Million CNY | 6.8% |
| 2017 Q3 | 17.76 Million CNY | -16.15% |
| 2017 Q2 | 21.18 Million CNY | 23.83% |
| 2016 Q2 | 15.32 Million CNY | 8.68% |
| 2016 FY | 67.14 Million CNY | 180.71% |
| 2016 Q1 | 14.09 Million CNY | 790.62% |
| 2016 Q4 | 16.01 Million CNY | -26.19% |
| 2016 Q3 | 21.7 Million CNY | 41.64% |
| 2015 Q2 | 1.66 Million CNY | -74.69% |
| 2015 Q4 | -2.04 Million CNY | -111.53% |
| 2015 Q3 | 17.7 Million CNY | 961.33% |
| 2015 FY | 23.91 Million CNY | -29.24% |
| 2015 Q1 | 6.59 Million CNY | -41.57% |
| 2014 Q2 | 8.12 Million CNY | 12.23% |
| 2014 Q3 | 7.15 Million CNY | -11.97% |
| 2014 Q4 | 11.27 Million CNY | 57.68% |
| 2014 FY | 33.8 Million CNY | 16.86% |
| 2014 Q1 | 7.24 Million CNY | 149.26% |
| 2013 Q1 | 5.41 Million CNY | -53.82% |
| 2013 Q3 | 9.76 Million CNY | -9.82% |
| 2013 Q4 | 2.9 Million CNY | -70.26% |
| 2013 FY | 28.92 Million CNY | -20.77% |
| 2013 Q2 | 10.83 Million CNY | 100.0% |
| 2012 Q1 | 3.7 Million CNY | -65.8% |
| 2012 Q4 | 11.72 Million CNY | 7.42% |
| 2012 Q3 | 10.91 Million CNY | 7.55% |
| 2012 FY | 36.5 Million CNY | 8.08% |
| 2012 Q2 | 10.15 Million CNY | 173.81% |
| 2011 Q1 | 2.41 Million CNY | -77.92% |
| 2011 FY | 33.77 Million CNY | 2.38% |
| 2011 Q2 | 15.38 Million CNY | 536.7% |
| 2011 Q4 | 10.84 Million CNY | 111.37% |
| 2011 Q3 | 5.12 Million CNY | -66.67% |
| 2010 Q3 | 8.17 Million CNY | 0.0% |
| 2010 Q4 | 10.94 Million CNY | 33.95% |
| 2010 FY | 32.99 Million CNY | 61.68% |
| 2009 FY | 20.4 Million CNY | 93.15% |
| 2008 FY | 10.56 Million CNY | 0.0% |